You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cardiovascular events

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Inclisiran on Major Adverse Cardiovascular Events in French

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • Inclisiran sodium
  • +3 more
  • (no location specified)
Jul 26, 2023

Frailty on Cardiovascular Events and Mortality in COPD.

Not yet recruiting
  • Role of Frailty in COPD
  • Assessment of cardiovascular events, cardiovascular mortality, all-cause mortality, and mortality due to COPD at 12 and 24 months
  • (no location specified)
Jun 19, 2023

Cardiovascular Diseases, Uric Acid Trial (Allopurinol 200 mg, Optional intervention)

Not yet recruiting
  • Cardiovascular Diseases
  • Uric Acid
  • Allopurinol 200 mg
  • Optional intervention
  • (no location specified)
Jul 5, 2023

Suspicion of Cardiovascular Events on Immunecheckpoint

Recruiting
  • Cancer
  • +3 more
  • No intervention for research purposes only
  • Paris, France
    Intitut Mutualiste Montsouris
Mar 23, 2023

Cardiovascular Diseases Trial in Nassau (Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))

Recruiting
  • Cardiovascular Diseases
  • Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
  • Nassau, The Bahamas, Bahamas
    The Partners Clinical Research Centre at The Medical Pavilion
Oct 17, 2023

Obesity Trial (Naltrexone-Bupropion (NB) Combination, Placebo)

Not yet recruiting
  • Obesity
  • Naltrexone-Bupropion (NB) Combination
  • Placebo
  • (no location specified)
Oct 18, 2023

Coronary Artery Disease Trial in Sacramento (device, behavioral, other)

Recruiting
  • Coronary Artery Disease
  • LiveCare
  • +2 more
  • Sacramento, California
    University of California, Davis Medical Center Division of Cardi
Oct 27, 2023

Ferroptosis in COPD COPD With/Without Risk of Cardiovascular

Recruiting
  • COPD Exacerbation
  • Non-interventional study
  • Santander, Cantabria, Spain
    Hospital Universitario Marqués de Valdecilla
Oct 25, 2023

Diabetes, Type 2, Major Adverse Cardiac Events Trial in Hangzhou (CGM)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Major Adverse Cardiac Events
  • CGM
  • Hangzhou, China
    the Second Affiliated Hospital Zhejiang University Schoolof Medi
Sep 23, 2023

Primary Cardiovascular Events Using the Multimarker Approach

Completed
  • Cardiovascular Diseases
  • +4 more
  • measurement of multiple biomarkers
  • (no location specified)
Jan 19, 2023

Major Adverse Cardiovascular Events in Coronary Artery Disease

Completed
  • Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease
    • Jinan, Shandong, China
      Yuguo Chen
    Sep 20, 2022

    Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)

    Not yet recruiting
    • Primary Prevention of Atherosclerotic Cardiovascular Disease
    • Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
    • Placebo in 1.5ml
    • (no location specified)
    Feb 13, 2023

    Myocardial Disease Trial in Milano, Roma (Sample blood)

    Active, not recruiting
    • Myocardial Disease
    • Sample blood
    • Milano, Italy
    • +1 more
    Feb 17, 2023

    Cardiovascular Events in Patients With Schizophrenia

    Recruiting
    • Schizophrenia
      • Shanghai, Shanghai, China
        Shanghai Mental Health Center
      Aug 11, 2022

      Arteriosclerosis, Hypercholesterolaemia Trial (MK-0616, Placebo)

      Not yet recruiting
      • Arteriosclerosis
      • Hypercholesterolaemia
      • (no location specified)
      Aug 17, 2023

      Triglyceride-Glucose Index on Cardiovascular Outcomes in

      Not yet recruiting
      • Major Cardiovascular Events
      • Triglyceride glucose index TyG
      • (no location specified)
      Oct 6, 2023

      Cardiovascular Diseases Trial in Shatin (TQJ230, Placebo)

      Active, not recruiting
      • Cardiovascular Diseases
      • Shatin, Hong Kong
        The Chinese University of Hong Kong
      Sep 16, 2022

      French National Observatory Tracking Viral Myocarditis:

      Completed
      • Myocarditis
      • +2 more
        • Paris, France
          Bichat
        Sep 15, 2022

        Diabetes, Type 2 Trial (Semaglutide Oral Tablet, Placebo oral tablet)

        Not yet recruiting
        • Diabetes Mellitus, Type 2
        • Semaglutide Oral Tablet
        • Placebo oral tablet
        • (no location specified)
        Jul 1, 2022

        Diabetes, Type 2, PreDiabetes, Metabolic Syndrome Trial (The Cleerly CAD Staging System)

        Not yet recruiting
        • Diabetes Mellitus, Type 2
        • +2 more
        • The Cleerly CAD Staging System
        • (no location specified)
        Oct 31, 2023

        Acute Coronary Syndrome, Hyperlipidemias, Percutaneous Coronary Intervention Trial in Nanjing (Placebo plus high-intensity

        Not yet recruiting
        • Acute Coronary Syndrome
        • +3 more
        • Placebo plus high-intensity statin
        • PCSK 9 Inhibitor plus high-intensity statin
        • Nanjing, Jiangsu, China
          Nanjing First Hospital
        Aug 1, 2022

        Prediction of Cardiovascular Events

        Recruiting
        • Cardiovascular Diseases
        • additional blood samples
        • Toulouse, France
          University Hospital Toulouse
        May 17, 2022

        Anticoagulant Drug Intervention on Postoperative MALE and MACE

        Recruiting
        • Anticoagulant Drugs
        • +2 more
        • anticoagulant or antiplatelet drugs
        • Hangzhou, None Selected, China
          First Affiliated Hospital of Zhejiang University
        May 8, 2023

        Cardiovascular Events by Platelet FcGammaRIIa

        Recruiting
        • STEMI
        • NSTEMI
          • Burlington, Vermont
            University of Vermont
          Apr 28, 2022

          s on Leukocyte Distribution, Monocyte Function and Platelet

          Recruiting
          • Arteriosclerosis
          • +3 more
            • Düsseldorf, Germany
              University-Hospital Düsseldorf Division of Cardiology, Pulmonary
            Aug 2, 2023